Cargando…
Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), has shifted our paradigms about B cell immunity and the goals of vaccination for respiratory viruses. The development of population immunity, through responses directed to highly...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349367/ https://www.ncbi.nlm.nih.gov/pubmed/35599324 http://dx.doi.org/10.1111/imr.13086 |